Description
This product utilizes CD4+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target CD22 ( clone IRO30). We employs the Retrovirus (CMV-GFP-NF-κB-BamHI) vector components and the SynExpress system of the coding regions Deletion/Positive feedback for a robust and sustained response against cancers.
Host
Humanized
Target
CD22
Clone
IRO30
Species Reactivity
Human
Cell Source
Synthetic CD4+ T cells
Sensor Gene
GFP
Promoter
CMV
Effector Gene
NF-κB
Insertion Sites
BamHI
Gene Modification
Deletion
Modification Domain
Coding regions
Carrier Type
Retrovirus
Transformation Accuracy
0.88
Cell Culture
Suspension Culture

For Research Use Only | Not For Clinical Use

Online Inquiry
Related Products
Copyright © 2025 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.